Author

Tara J. O’Donohue

Observed names: T. O'Donohue, T. O’Donohue, T. O’donohue, Tara J. O'Donohue, Tara O'Donohue, Tara O'Donohue MD, Tara O’Donohue

Institution: Memorial Sloan Kettering Cancer Center

Observed institutions: Amgen (United States), Memorial Sloan Kettering Cancer Center, NewYork–Presbyterian Hospital, Cornell University, Weill Cornell Medicine, Weill Cornell Medical Center

ORCID: 0000-0001-9814-0690

Observed ORCID: 0000-0001-9814-0690

OpenAlex ID: A5040223652

Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted EPOCH ‐R

2017 · Lisa Giulino‐Roth, Tara O'Donohue, et al. · British Journal of Haematology · 131

PDF

Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers

2022 · N. Shukla, M. F. Levine, et al. · Nature Communications · 76

PDF

Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma

2023 · Michael D. Kinnaman, Simone Zaccaria, et al. · Cancer Research · 30

PDF

A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma.

2022 · Emily K Slotkin, Audrey Mauguen, et al. · Journal of Clinical Oncology · 15

Translational Strategies for Repotrectinib in Neuroblastoma

2021 · Tara J. O'Donohue, Glorymar Ibáñez, et al. · Molecular Cancer Therapeutics · 13

Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience

2017 · Lisa Giulino-Roth, Tara O’Donohue, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13

Progress in precision therapy in pediatric oncology

2022 · Tara O’Donohue, Sameer Farouk Sait, et al. · Current Opinion in Pediatrics · 10

Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials

2024 · Damon R. Reed, Asmin Tulpule, et al. · Journal of Clinical Oncology · 6

PDF

ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results

2025 · Emily K. Slotkin, Audrey Mauguen, et al. · JCO oncology advances. · 5

Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology

2025 · Dylan Domenico, Gunes Gundem, et al. · Nature Communications · 3

PDF

Abstract 727: Association of baseline tumor and peripheral biomarker features with efficacy in metastatic castration-resistant prostate cancer patients treated with xaluritamig

2025 · Benjamin E. Decato, Zhao Yang, et al. · Cancer Research · 2

Abstract 704: Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine

2022 · Filemon S. Dela Cruz, Joseph G. McCarter, et al. · Cancer Research · 2

Improving Global Access to Genomic Profiling in Rare Pediatric Cancers

2025 · Sameer Farouk Sait, Tara J. O’Donohue, et al. · Clinical Cancer Research · 1

Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma

2023 · Michael D. Kinnaman, Simone Zaccaria, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

PDF

Feasibility and clinical utility of cancer whole genome and transcriptome sequencing for pediatric and young adult solid tumors.

2021 · Neerav Shukla, Max Levine, et al. · Journal of Clinical Oncology · 1

TPX-0005 (Repotrectinib), a next-generation ALK/ROS1/NTRK1–3 inhibitor, has potent antiproliferative and anti-tumor activity as monotherapy and in combination with chemotherapy in neuroblastoma cell lines and pediatric patient derived xenograft models

2020 · T. O’donohue, G. Ibáñez, et al. · European Journal of Cancer · 1

PDF

OUTCOMES OF ADULTS, ADOLESCENTS, AND CHILDREN WITH PRIMARY MEDIASTINAL B‐CELL LYMPHOMA TREATED WITH DOSE‐ADJUSTED EPOCH‐R THERAPY: a MULTICENTER RETROSPECTIVE ANALYSIS

2017 · L.G. Roth, T. O'Donohue, et al. · Hematological Oncology · 1

PDF

Phase II Trial of Irinotecan and Temozolomide in Combination With Existing High-Dose Alkylator–Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

2026 · Emily K. Slotkin, Audrey Mauguen, et al. · JCO oncology advances.

Author Correction: Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers

2025 · N. Shukla, M. F. Levine, et al. · Nature Communications

PDF

61034 Microbial Diversity Associated with Nail Toxicities in Fibroblast Growth Factor Receptor Inhibitor Treated Patients

2025 · Alexander S. Bang, Allison Gordon, et al. · Journal of the American Academy of Dermatology

Supplementary Table 3 from Improving Global Access to Genomic Profiling in Rare Pediatric Cancers